Bernard Jégou firstname.lastname@example.org 02 23 23 69 11
A new study conducted by Inserm researchers at Irset (Institute of Research in Environmental and Occupational Health) shows that ibuprofen is liable to cause disruptions in the hormone system in the human foetal testis, with possible implications for the development of the male urogenital tract. This drug suppresses the production of various testicular hormones, including testosterone, which controls the primary and secondary sex characteristics and the descent of the testes. These effects are obtained at doses similar to the standard dosage. These results are published in Scientific Reports.
Ibuprofen, which can be obtained without prescription, is one of the drugs most commonly consumed by pregnant women. Although nearly one woman in ten reports having taken ibuprofen during her pregnancy, studies indicate that in reality up to 3 in 10 have self-medicated with it.
Epidemiological studies conducted in recent years have shown a link between taking analgesics during pregnancy and the occurrence of adverse effects in the child (low birthweight, asthma, premature birth etc.). Other research combining epidemiology, in utero experimentation in rats and ex vivo on rat and human organs, undertaken at Irset in collaboration with Danish researchers from the University of Copenhagen, showed that paracetamol and aspirin could disrupt the endocrine system of the foetal testis, resulting in an increased risk of failure of the testes to descend (cryptorchidism). Only the effects of ibuprofen had not yet been tested.
To do that, the Irset researchers – with the support of colleagues at Rennes University Hospital and the University of Copenhagen, researchers from Laberca (Laboratory for the Study of Residues and Contaminants in Food) in Nantes, and Scots colleagues from MRC Edinburgh – conducted two series of tests to study the effects of ibuprofen on the human foetal testis. In the first series of studies, the testes were cultured; in the second, they were grafted onto mice. The effects of ibuprofen were studied over periods corresponding to the 1st and 2nd trimesters of pregnancy.
Moreover, expression of the genes needed for the germ cells, the progenitors of spermatozoa, to function is considerably reduced in the presence of ibuprofen.
Finally, production of prostaglandin E2 (known to be produced by the testes, and known to be involved in many biological processes) and the corresponding genes are also inhibited by the presence of ibuprofen at the same developmental age.
All these effects are observed very early in the first trimester, and none of them is found in tests conducted during the second trimester.
For Bernard Jégou, Inserm Research Director and coordinator of this study, and Séverine Mazaud-Guittot, Inserm Research Fellow, the conclusions of this work, which was supported by the French National Agency of Medicine and Health Products Safety (ANSM), are to be taken seriously: “There is a well-defined window of sensitivity during the 1st trimester of foetal development during which ibuprofen seems to present a risk for the future genital and reproductive system of the child. All the indications point to the need for great prudence regarding the use of this drug during the 1st trimester of pregnancy. Furthermore, if we now take the body of available data into account, it seems that taking several analgesics during pregnancy represents an even greater danger for the hormonal balance of the male foetus.”
 Xenografting is the transplantation of cells or organ fragments from one living organism (e.g. human cells) into the body of another species (here the mouse) in order to understand their development.
 Institute of Research in Environmental and Occupational Health; Inserm; French School of Public Health (EHESP), University of Rennes 1.
For a deeper insight into the social and epidemiological challenges posed by the exceptional prevention measures taken in response to the COVID-19 pandemic – particularly confinement – a multidisciplinary group of researchers has joined forces with Inserm and the Public Health Agency ...
Ibuprofen results in alterations of human fetal testis development Millissia Ben Maamar1, Laurianne Lesné1, Kristin Hennig2, Christèle Desdoits-Lethimonier1, Karen R. Kilcoyne3, Isabelle Coiffec1, Antoine D. Rolland1, Cécile Chevrier1, David M. Kristensen4, Vincent Lavoué5, Jean-Philippe Antignac2, Bruno Le Bizec2, Nathalie Dejucq-Rainsford1, Rod T. Mitchell3, Séverine Mazaud-Guittot1, Bernard Jégou1,6* 1Institut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset – Inserm UMR 1085), 9 avenue Léon Bernard, F-35000 RENNES, France. Université de Rennes 1, F-35043 RENNES, France. 2LUNAM Université, Oniris, USC INRA 1329, Laboratoire d'Etude des Résidus et Contaminants dans les Aliments (LABERCA), Nantes, F-44307, France. 3MRC Centre for Reproductive Health, University of Edinburgh, Queens Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ. 4Laboratorium of Genomic and Molecular Biomedicine, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen N, Denmark. 5CHU de Rennes, Service de Gynécologie, Hôpital Sud, 16, boulevard de Bulgarie, F-35700 Rennes, France; Université de Rennes 1, Faculté de Médecine, F-35043 RENNES, France. 6Ecole des hautes études en santé publique (EHESP), Avenue Léon Bernard, F-35043 RENNES,France.